Skip to main content
Category

News

News

Optimapharm confirms Mirna Šenjug Novak as Group CFO

Optimapharm confirms Mirna Šenjug Novak as Group CFO   Optimapharm, a leading, mid-sized, full-service CRO (Contract Research Organization) across Europe and North America, is excited to announce the promotion of Mirna Šenjug Novak as Group Chief Financial Officer (CFO), effective February…
Marie Garchon
April 28, 2023
News

Optimapharm announces EUCROF webinar presentation

Person-Centric Clinical Trials - Webinar Optimapharm announces Ana Stojković as a speaker at the EUCROF webinar - Person-Centric Clinical Trials.  Optimapharm is delighted to share that our VP of Clinical Operations - Ana Stojković, will be one of the speakers…
Marie Garchon
October 3, 2022
News

Optimapharm Conference Attendance in Q3 & Q4 of 2022

Optimapharm Announces Conferences Attendance in Q4 of 2022 Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce its attendance at conferences in Q4 of 2022. BIO EUROPE 2022 BIO-Europe has a long track…
Marie Garchon
September 28, 2022
News

Optimapharm Announces Acquisition of Qualitis SA

Optimapharm Announces Acquisition of Qualitis SA We Deliver on Your Promises Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce the acquisition of Qualitis SA (“Qualitis”). This acquisition will complement Optimapharm’s geographic coverage…
Marie Garchon
June 27, 2022
News

Taiga Biotechnologies important milestone

Taiga Biotechnologies important milestone Reaching a milestone Optimapharm is pleased to announce we have reached an important milestone on Taiga Biotechnologies Inc. TBX-2400-01 study initiating first site in Croatia for patients undergoing hematopoietic stem cell transplant (HSCT). #teamOptimapharm is excited…
info@rolandkoves.design
November 29, 2021
Optimapharm